9th International Iranian Heart Failure Summit

Since the first International Iranian Heart Failure Summit, now in its ninth round, we have witnessed remarkable progress and numerous innovations in the field of technology and drug treatment for this condition. New medications, devices, and diagnostic methods have come together to help us find solutions for a disease with a mortality rate higher than cancer, offering patients both hope and the possibility of a symptom-free life. Yet, from the very beginning of the Summit, one key point has remained at the forefront of our minds: heart failure is often the result of the progression of various heart diseases in the absence of preventive measures. Therefore, if we truly wish to make a significant and lasting impact on the course of these diseases, we must always place prevention before treatment.

I hope that by drawing on the scientific insights presented at this Summit by my esteemed colleagues in the fields of diagnosis, prevention, and treatment of heart failure, we will not only contribute to reducing the complications and challenges faced by patients living with this condition, but also, through the prevention of cardiovascular diseases and the reduction of risk factors in society, we will lessen the need for advanced, complex, and costly interventions by promoting timely and early diagnosis.